Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes
Shimon, S
In our practice, constipation is one of the most consistently reported problems on GLP-1 therapy, particularly in the first weeks of a new dose
Research and clinical observations suggest that targeted supplementation can help improve certain behaviors and biological markers
What should I do if I miss a dose of Wegovy
US$ 22.81
US$ 27.45
US$ 20.82
US$ 20.58
